- Home
- BV vs CVAC Comparison
BV vs CVAC Comparison
Compare BV & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BV
- CVAC
- Stock Information
- Founded
- BV 1939
- CVAC 2000
- Country
- BV United States
- CVAC Germany
- Employees
- BV N/A
- CVAC N/A
- Industry
- BV Business Services
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- BV Consumer Discretionary
- CVAC Health Care
- Exchange
- BV Nasdaq
- CVAC Nasdaq
- Market Cap
- BV 1.5B
- CVAC 1.2B
- IPO Year
- BV 2018
- CVAC 2020
- Fundamental
- Price
- BV $16.36
- CVAC $5.45
- Analyst Decision
- BV Buy
- CVAC Hold
- Analyst Count
- BV 7
- CVAC 3
- Target Price
- BV $17.82
- CVAC $6.83
- AVG Volume (30 Days)
- BV 755.6K
- CVAC 805.8K
- Earning Date
- BV 08-06-2025
- CVAC 08-14-2025
- Dividend Yield
- BV N/A
- CVAC N/A
- EPS Growth
- BV N/A
- CVAC N/A
- EPS
- BV N/A
- CVAC 0.87
- Revenue
- BV $2,729,300,000.00
- CVAC $566,039,775.00
- Revenue This Year
- BV $1.19
- CVAC N/A
- Revenue Next Year
- BV $3.14
- CVAC $24.04
- P/E Ratio
- BV N/A
- CVAC $6.28
- Revenue Growth
- BV N/A
- CVAC 787.60
- 52 Week Low
- BV $11.81
- CVAC $2.37
- 52 Week High
- BV $18.89
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- BV 52.99
- CVAC 58.69
- Support Level
- BV $15.39
- CVAC $5.35
- Resistance Level
- BV $16.53
- CVAC $5.50
- Average True Range (ATR)
- BV 0.34
- CVAC 0.05
- MACD
- BV -0.00
- CVAC -0.03
- Stochastic Oscillator
- BV 57.71
- CVAC 68.97
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.